High blood pressure frequently exists as part of a broader syndrome of cardiovascular and metabolic abnormalities, requiring individualized treatment approaches beyond blood pressure reduction alone.
HYPERTENSION CONTINUES to be one of the most common conditions treated by physicians. Ongoing research has better defined the mechanisms and clinical characteristics of this condition and enlarged the scope of therapeutic options. It is increasingly clear that high blood pressure, although an independent risk factor for adverse clinical events, frequently exists as part of a syndrome of cardiovascular, neuroendocrine, and metabolic abnormalities.1-3Prognosis and appropriate treatment for the individual patient must, therefore, be based on considerations that go beyond blood pressure itself. The Joint National Committee (JNC) on the Detection, Evaluation, and Treatment of High Blood Pressure has given opinions on the management of hypertension at 4-year intervals for almost 20 years. The recently published fifth report of the JNC (JNC V) concerning high blood pressure, presented as two separate and lengthy articles,4,5offers detailed commentary on newer developments in the diagnosis and managementof hypertension, especially as
Michael A. Weber (Mon,) conducted a editorial in Hypertension. High blood pressure frequently exists as part of a broader syndrome of cardiovascular and metabolic abnormalities, requiring individualized treatment approaches beyond blood pressure reduction alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: